Immunotherapy maintenance therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy maintenance therapy, covering 2025-07-08 to 2025-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)